228 related articles for article (PubMed ID: 28445321)
1. Clinical analysis and prognosis of synchronous and metachronous multiple primary malignant tumors.
Lv M; Zhang X; Shen Y; Wang F; Yang J; Wang B; Chen Z; Li P; Zhang X; Li S; Yang J
Medicine (Baltimore); 2017 Apr; 96(17):e6799. PubMed ID: 28445321
[TBL] [Abstract][Full Text] [Related]
2. High incidence combination of multiple primary malignant tumors of the digestive system.
Yang XB; Zhang LH; Xue JN; Wang YC; Yang X; Zhang N; Liu D; Wang YY; Xun ZY; Li YR; Sun HS; Zhao LJ; Zhao HT
World J Gastroenterol; 2022 Nov; 28(41):5982-5992. PubMed ID: 36405110
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics and prognosis associated with multiple primary malignant tumors in non-Hodgkin lymphoma patients.
Jiang Y; Miao Z; Wang J; Chen J; Lv Y; Xing D; Wang X; Wang Y; Cao Z; Zhao Z
Tumori; 2019 Dec; 105(6):474-482. PubMed ID: 30945608
[TBL] [Abstract][Full Text] [Related]
4. Clinical analysis of 152 cases of multiple primary malignant tumors in 15,398 patients with malignant tumors.
Liu Z; Liu C; Guo W; Li S; Bai O
PLoS One; 2015; 10(5):e0125754. PubMed ID: 25945938
[TBL] [Abstract][Full Text] [Related]
5. Multiple Primary Malignant Tumors - A Clinical Analysis of 15,321 Patients with Malignancies at a Single Center in China.
Zhai C; Cai Y; Lou F; Liu Z; Xie J; Zhou X; Wang Z; Fang Y; Pan H; Han W
J Cancer; 2018; 9(16):2795-2801. PubMed ID: 30123347
[No Abstract] [Full Text] [Related]
6. Clinical analysis of multiple primary gastrointestinal malignant tumors: A 10-year case review of a single-center.
Zhu CL; Peng LZ
World J Gastrointest Oncol; 2024 Apr; 16(4):1204-1212. PubMed ID: 38660651
[TBL] [Abstract][Full Text] [Related]
7. Multiple Primary Tumors Originating From the Prostate and Colorectum A Clinical-Pathological and Therapeutic Challenge.
Dema S; Bota A; Tăban SM; Gheju A; Dema ALC; Croitor A; Barna RA; Popa O; Bardan R; Cumpănaș AA
Am J Mens Health; 2021; 15(5):15579883211044881. PubMed ID: 34493123
[TBL] [Abstract][Full Text] [Related]
8. Bilateral Breast Cancer After Multimodality Treatment: A Report of Clinical Outcomes in an Asian Population.
Wadasadawala T; Lewis S; Parmar V; Budrukkar A; Gupta S; Nair N; Shet T; Badwe R; Sarin R
Clin Breast Cancer; 2018 Aug; 18(4):e727-e737. PubMed ID: 29254601
[TBL] [Abstract][Full Text] [Related]
9. Synchronous Metastatic Clear-Cell Renal Cell Carcinoma: A Distinct Morphologic, Immunohistochemical, and Molecular Phenotype.
Kammerer-Jacquet SF; Brunot A; Pladys A; Bouzille G; Dagher J; Medane S; Peyronnet B; Mathieu R; Verhoest G; Bensalah K; Edeline J; Laguerre B; Lespagnol A; Mosser J; Dugay F; Belaud-Rotureau MA; Rioux-Leclercq N
Clin Genitourin Cancer; 2017 Feb; 15(1):e1-e7. PubMed ID: 27444986
[TBL] [Abstract][Full Text] [Related]
10. Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease.
Heron DE; Komarnicky LT; Hyslop T; Schwartz GF; Mansfield CM
Cancer; 2000 Jun; 88(12):2739-50. PubMed ID: 10870056
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic Features and Prognosis of Sporadic Bilateral Renal Cell Carcinoma: A Series of 148 Cases.
Qi N; Li T; Ning X; Peng X; Cai L; Gong K
Clin Genitourin Cancer; 2017 Oct; 15(5):618-624. PubMed ID: 28648756
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Factors for Survival of Patients With Synchronous or Metachronous Brain Metastasis of Renal Cell Carcinoma.
Choi SY; Yoo S; You D; Jeong IG; Song C; Hong B; Hong JH; Ahn H; Kim CS
Clin Genitourin Cancer; 2017 Dec; 15(6):717-723. PubMed ID: 28552571
[TBL] [Abstract][Full Text] [Related]
13. [Synchronous and metachronous myeloid and lymphoid tumors].
Melikian AL; Kolosheĭnova TI; Goriacheva SR; Subortseva IN; Vakhrusheva MV; Kolosova EN; Sudarikov AB; Abdullaev AO; Dvirnyk VN; Varlamova EIu; Kovrigina AM; Turkina AG
Ter Arkh; 2014; 86(7):37-44. PubMed ID: 25314776
[TBL] [Abstract][Full Text] [Related]
14. Synchronous and "early" metachronous colorectal adenocarcinoma: analysis of prognosis and current trends.
Chen HS; Sheen-Chen SM
Dis Colon Rectum; 2000 Aug; 43(8):1093-9. PubMed ID: 10950007
[TBL] [Abstract][Full Text] [Related]
15. Impact of Synchronous Versus Metachronous Onset of Colorectal Peritoneal Metastases on Survival Outcomes After Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Multicenter, Retrospective, Observational Study.
Hentzen JEKR; Rovers KP; Kuipers H; van der Plas WY; Been LB; Hoogwater FJH; van Ginkel RJ; Hemmer PHJ; van Dam GM; de Hingh IHJT; Kruijff S
Ann Surg Oncol; 2019 Jul; 26(7):2210-2221. PubMed ID: 30877495
[TBL] [Abstract][Full Text] [Related]
16. Multiple metachronous rare primary malignant tumors: A case report.
Ying X; Zhang H; Chen B; Wu H; Bao L; Qian S; Ying X
Thorac Cancer; 2019 Oct; 10(10):2050-2053. PubMed ID: 31454854
[TBL] [Abstract][Full Text] [Related]
17. Dual primary gastric and colorectal cancer: is the prognosis better for synchronous or metachronous?
Watanabe M; Kochi M; Fujii M; Kaiga T; Mihara Y; Funada T; Tamegai H; Shimizu H; Takayama T
Am J Clin Oncol; 2012 Oct; 35(5):407-10. PubMed ID: 21659834
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancer.
Fleckenstein J; Petroff A; Schäfers HJ; Wehler T; Schöpe J; Rübe C
BMC Cancer; 2016 Jun; 16():348. PubMed ID: 27255302
[TBL] [Abstract][Full Text] [Related]
19. Multiple Pulmonary Resections for Synchronous and Metachronous Lung Cancer at Two Chinese Centers.
Kang X; Zhang C; Zhou H; Zhang J; Yan W; Zhong WZ; Chen KN
Ann Thorac Surg; 2020 Mar; 109(3):856-863. PubMed ID: 31765616
[TBL] [Abstract][Full Text] [Related]
20. Synchronous and metachronous skeletal osteosarcomas: the Norwegian Radium Hospital experience.
Brandal P; Bjerkehagen B; Bruland OS; Skjeldal S; Bogsrud TV; Hall KS
Acta Oncol; 2009; 48(8):1165-72. PubMed ID: 19863225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]